Matthew Ewles

发表

LC-MS/MS strategies for therapeutic antibodies and investigation into the quantitative impact of antidrug-antibodies.

J. Duffy, Sian Estdale, David Firth, 2016, Bioanalysis.

Development of a bioanalytical method for quantification of a 15-mer oligonucleotide at sub-ng/ml concentrations using LC-MS/MS.

L. Goodwin, Matthew Ewles, M. Hemsley, 2012, Bioanalysis.

Case studies: the impact of nonanalyte components on LC-MS/MS-based bioanalysis: strategies for identifying and overcoming matrix effects.

Fumin Li, Michael Blackburn, A. Ledvina, 2013, Bioanalysis.

Quantification of oligonucleotides by LC-MS/MS: the challenges of quantifying a phosphorothioate oligonucleotide and multiple metabolites.

A. Schneider, L. Goodwin, Matthew Ewles, 2014, Bioanalysis.

High-sensitivity workflow for LC-MS-based analysis of GalNAc-conjugated oligonucleotides: a case study.

D. Good, P. Severin, A. Ledvina, 2021, Bioanalysis.

Determination of osimertinib in human plasma, urine and cerebrospinal fluid.

Matthew Ewles, Christopher Bailey, G. Swan, 2019, Bioanalysis.

Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.

Lee Goodwin, Matthew Ewles, L. Goodwin, 2011, Bioanalysis.

Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS.

L. Goodwin, Matthew Ewles, Phillip E Turpin, 2011, Biomedical chromatography : BMC.

Whole blood stability in quantitative bioanalysis.

Yongle Pang, A. Ledvina, Matthew Ewles, 2019, Bioanalysis.

High-sensitivity workflow for LC-MS-based analysis of GalNAc-conjugated oligonucleotides: a case study.

D. Good, P. Severin, A. Ledvina, 2021, Bioanalysis.